168 related articles for article (PubMed ID: 33349878)
1. The role of medicine donations in the global programme for the elimination of lymphatic filariasis.
Williams T; Taylor R; Iwamoto M; Hida T; Gusovsky F
Int Health; 2020 Dec; 13(Suppl 1):S39-S43. PubMed ID: 33349878
[TBL] [Abstract][Full Text] [Related]
2. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Ottesen EA; Horton J
Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
[TBL] [Abstract][Full Text] [Related]
3. Elimination of lymphatic filariasis as a public health problem in Malawi.
Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
[TBL] [Abstract][Full Text] [Related]
4. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Gustavsen KM; Bradley MH; Wright AL
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
[TBL] [Abstract][Full Text] [Related]
6. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
[TBL] [Abstract][Full Text] [Related]
7. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
[TBL] [Abstract][Full Text] [Related]
8. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
Devi RR; Raju V
J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
[TBL] [Abstract][Full Text] [Related]
9. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
Fang Y; Zhang Y
Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
[TBL] [Abstract][Full Text] [Related]
10. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic tools for filariasis elimination programs.
Weil GJ; Ramzy RM
Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
[TBL] [Abstract][Full Text] [Related]
12. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
Turner HC; Ottesen EA; Bradley MH
Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
[TBL] [Abstract][Full Text] [Related]
13. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
[TBL] [Abstract][Full Text] [Related]
14. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
Krentel A; Gyapong M; McFarland DA; Ogundahunsi O; Titaley CR; Addiss DG
Int Health; 2020 Dec; 13(Supplement_1):S55-S59. PubMed ID: 33349882
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.
Gedge LM; Bettis AA; Bradley MH; Hollingsworth TD; Turner HC
Parasit Vectors; 2018 Feb; 11(1):75. PubMed ID: 29391042
[TBL] [Abstract][Full Text] [Related]
16. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
17. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
Houston R
Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
[TBL] [Abstract][Full Text] [Related]
18. The global programme to eliminate lymphatic filariasis.
Ottesen EA
Trop Med Int Health; 2000 Sep; 5(9):591-4. PubMed ID: 11044272
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.
El Setouhy M; Ramzy RM
East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050
[TBL] [Abstract][Full Text] [Related]
20. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.
Alexander ND
Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):173-4. PubMed ID: 25575555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
